CurveBeam AI Expands Stryker Partnership to Boost WBCT Demand in ANZ

Strategic Expansion into Australia and New Zealand

CurveBeam AI Limited (ASX: CVB), a specialist in weight bearing CT (WBCT) imaging technology, has announced a significant expansion of its commercial partnership with Stryker Australia Pty Ltd. The new exclusive referral agreement extends Stryker’s role to the Australia and New Zealand territories, marking a strategic move to deepen CurveBeam AI’s market penetration in its home region.

Under this three-year deal, with a potential two-year extension, Stryker will leverage its 25-plus strong sales force to directly educate orthopaedic surgeons on the clinical benefits of CurveBeam AI’s HiRise WBCT scanner. This education initiative aims to stimulate demand by enhancing surgeon awareness and understanding of WBCT’s advantages in lower extremity orthopaedic applications.

Driving Demand Through Surgeon Education and Referrals

The agreement is structured around minimum referral volumes that translate into sales and commissions, ensuring a performance-driven partnership. Stryker’s established presence and resources in the region are expected to be instrumental in generating qualified sales leads, which CurveBeam AI will then convert through direct sales to imaging centres and hospitals.

This approach contrasts with CurveBeam AI’s previous distribution model in Australia, which ended in 2024. The new arrangement with Stryker represents a material expansion of CurveBeam AI’s market opportunity, combining Stryker’s extensive sales reach with CurveBeam AI’s specialised technology and direct customer relationships.

Implications for CurveBeam AI’s Growth Trajectory

CEO Greg Brown expressed enthusiasm about the partnership, highlighting the synergy between the two companies. He emphasized that Stryker’s scale and reach will be critical in driving surgeon demand, which in turn will support the placement of HiRise scanners in key clinical settings. This could accelerate adoption of WBCT technology, which offers distinct advantages over traditional CT and MRI by enabling weight bearing scans that improve diagnosis and surgical planning.

With over 70 employees globally and dual headquarters in Melbourne and Pennsylvania, CurveBeam AI is well positioned to capitalise on this expanded collaboration. The company’s focus on integrating AI-powered clinical assessment solutions with its imaging hardware further differentiates its offering in the competitive medical imaging landscape.

Investors and industry watchers will be keen to monitor how effectively the education programs translate into increased scanner placements and revenue growth in the ANZ region over the coming quarters.